SCHEMBL9531495

SCHEMBL9531495

CC1(C)Nc2ccc(Br)cc2C(N2CCCC2=O)C1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.43
▸ ABCC9 O60706 2/20 0.43
▸ ABCC8 Q09428 2/20 0.43
▸ KCNJ11 Q14654 2/20 0.43
▸ KCNJ8 Q15842 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ PKM P14618 2/20 0.37
▸ KMT2A Q03164 3/20 0.35
▸ POLB P06746 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ LRRK2 Q5S007 1/20 0.34
▸ PGR P06401 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ TP53 P04637 3/20 0.33
▸ GAA P10253 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9529808 1.00 LMNA (0.43) LMNAABCC9ABCC8KCNJ11KCNJ8
SCHEMBL10538984 1.00 LMNA (0.43) LMNAABCC9ABCC8KCNJ11KCNJ8
SCHEMBL9531501 1.00 LMNA (0.43) LMNAABCC9ABCC8KCNJ11KCNJ8
SCHEMBL10543412 1.00 LMNA (0.43) LMNAABCC9ABCC8KCNJ11KCNJ8
SCHEMBL9530832 0.86 ABCC9 (0.43) LMNAABCC9ABCC8KCNJ11KCNJ8
SCHEMBL9531246 0.86 ABCC9 (0.43) LMNAABCC9ABCC8KCNJ11KCNJ8
SCHEMBL9530830 0.86 ABCC9 (0.43) LMNAABCC9ABCC8KCNJ11KCNJ8
SCHEMBL10646281 0.84 LMNA (0.37) LMNACYP2C19PKMKMT2APOLB
SCHEMBL9530450 0.83 ABCC9 (0.64) LMNAABCC9ABCC8KCNJ11KCNJ8
SCHEMBL9530480 0.83 ABCC9 (0.64) LMNAABCC9ABCC8KCNJ11KCNJ8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0214743-B1 USE OF QUINOLINE DERIVATIVES IN THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF CEREBROVASCULAR DISORDERS AND CEREBRAL SENILITY BEECHAM GROUP PLC (GB) 1993-05-12 — — EP claimed
US-4808619-A HYPOTENSIVE AGENT, COGNITION ACTIVATOR BEECHAM GROUP P.L.C. (GB) 1989-02-28 — — US claimed
EP-0150202-B1 DI/TETRA-HYDROQUINOLINES BEECHAM GROUP PLC (GB) 1988-07-06 — — EP claimed
EP-0214743-A2 Use of quinoline derivatives in the manufacture of medicaments for the treatment of cerebrovascular disorders and cerebral senility BEECHAM GROUP PLC (GB) 1987-03-18 — — EP claimed
EP-0214743-B1 USE OF QUINOLINE DERIVATIVES IN THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF CEREBROVASCULAR DISORDERS AND CEREBRAL SENILITY BEECHAM GROUP PLC (GB) 1993-05-12 — — EP disclosed
US-4808619-A HYPOTENSIVE AGENT, COGNITION ACTIVATOR BEECHAM GROUP P.L.C. (GB) 1989-02-28 — — US disclosed
EP-0150202-B1 DI/TETRA-HYDROQUINOLINES BEECHAM GROUP PLC (GB) 1988-07-06 — — EP disclosed
EP-0214743-A2 Use of quinoline derivatives in the manufacture of medicaments for the treatment of cerebrovascular disorders and cerebral senility BEECHAM GROUP PLC (GB) 1987-03-18 — — EP disclosed
EP-0150202-A1 DI/TETRA-HYDROQUINOLINES. BEECHAM GROUP PLC (GB) 1985-08-07 — — EP disclosed
WO-1985000602-A1 DI/TETRA-HYDROQUINOLINES BEECHAM GROUP P.L.C. (GB) 1985-02-14 — — WO disclosed
Send feedback